Correlation Between Lexaria Bioscience and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Lexaria Bioscience and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lexaria Bioscience and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lexaria Bioscience Corp and Virax Biolabs Group, you can compare the effects of market volatilities on Lexaria Bioscience and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lexaria Bioscience with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lexaria Bioscience and Virax Biolabs.
Diversification Opportunities for Lexaria Bioscience and Virax Biolabs
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Lexaria and Virax is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Lexaria Bioscience Corp and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Lexaria Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lexaria Bioscience Corp are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Lexaria Bioscience i.e., Lexaria Bioscience and Virax Biolabs go up and down completely randomly.
Pair Corralation between Lexaria Bioscience and Virax Biolabs
Given the investment horizon of 90 days Lexaria Bioscience Corp is expected to generate 1.45 times more return on investment than Virax Biolabs. However, Lexaria Bioscience is 1.45 times more volatile than Virax Biolabs Group. It trades about 0.01 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about -0.25 per unit of risk. If you would invest 230.00 in Lexaria Bioscience Corp on September 13, 2024 and sell it today you would lose (5.00) from holding Lexaria Bioscience Corp or give up 2.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lexaria Bioscience Corp vs. Virax Biolabs Group
Performance |
| Timeline |
| Lexaria Bioscience Corp |
| Virax Biolabs Group |
Lexaria Bioscience and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lexaria Bioscience and Virax Biolabs
The main advantage of trading using opposite Lexaria Bioscience and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lexaria Bioscience position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Lexaria Bioscience vs. Revelation Biosciences | Lexaria Bioscience vs. Zura Bio Limited | Lexaria Bioscience vs. Phio Pharmaceuticals Corp | Lexaria Bioscience vs. ZyVersa Therapeutics |
| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |